Vaxil Bio
Lior Carmon
lior.carmon@nullvaxilbio.com
+972-54-5201166
Vaxil BioTherapeutics Ltd. (TASE:VAXL), is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology.
Get more BANG for your BUCK at industry events.
Aneeva's Event Optimization Service helps you drive sales and maximize ROI from industry events via pre-set sales meetings with targeted customers.